Not finding it? Sign in to also search OpenAlex live.
-
The TESTBREAST journey: Revisiting the importance of early detection by frequent screening of women at high risk of breast cancer2025 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Layla Andour, Sophie C. Hagenaars, Kiki M. H. Vangangelt, Janneke Aalberts, Valerie Rebattu, Elma Meershoek‐Klein Kranenbarg, +4 more
1citations -
Abstract PD6-5: The association between radiotherapy and contralateral breast cancer risk in young BRCA1/2-associated breast cancer patients2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer
Mark van Barele, Delal Akdeniz, Bernadette A. M. Heemskerk‐Gerritsen, Margreet H.A. Baaijens, Margriet G. A. Sattler, Marjanka K. Schmidt, +2 more
0citations -
Additional file 13 of Exploring the link between MORF4L1 and risk of breast cancer2020 Figshare dataset Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Griselda Martrat, Christopher A. Maxwell, Emiko Tominaga, Montserrat Porta-de-la-Riva, Núria Bonifaci, Laia Gómez‐Baldó, +92 more
0citations -
Update Mammakarzinom 2021 Teil 4 – Prävention und frühe Krankheitsstadien2022 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Christoph Thomssen, Tanja Natascha Fehm, Elmar Stickeler, Peter Andreas Fasching, Wolfgang Janni, Cornelia Kolberg‐Liedtke, +17 more
0citations -
Rare copy number variants (CNVs) and breast cancer risk2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Genomic variations and chromosomal abnormalities Open access
Joe Dennis, Jonathan P. Tyrer, Logan C. Walker, Kyriaki Michailidou, Leila Dorling, Manjeet K. Bolla, +89 more
0citations -
The contribution of rare germline variants to the immune landscape of breast cancer2026 Genome Medicine article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Felipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, Aaron J. Bernstein, Amber N. Hurson, Thomas U. Ahearn, +40 more
0citations -
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Cristiana Sessa, Judith Balmañà, Sharon L. Bober, Maria João Cardoso, N. Colombo, Giuseppe Curigliano, +12 more
296citations -
The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer2021 Nature Cancer article Biochemistry, Genetics and Molecular Biology DNA Repair Mechanisms Open access cited by 1 patent
Salomé Adam, Silvia Emma Rossi, Nathalie Moatti, Mara De Marco Zompit, Yibo Xue, Timothy F. Ng, +19 more
119citations -
Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation2020 Journal of Medical Genetics article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Álvaro N.A. Monteiro, Arne Nedergaard Kousholt, Diana Eccles, Gaël A. Millot, Jean‐Yves Masson, Marjanka K. Schmidt, +5 more
48citations -
Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis2021 Gynecologic Oncology review Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Vera M. Witjes, Majke H.D. van Bommel, Marjolijn J. L. Ligtenberg, Janet R. Vos, Marian J.E. Mourits, Margreet G.E.M. Ausems, +2 more
44citations -
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation2023 JNCI Journal of the National Cancer Institute article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Mark van Barele, Delal Akdeniz, Bernadette A. M. Heemskerk‐Gerritsen, Nadine Andrieu, Catherine Noguès, Christi J. van Asperen, +28 more
11citations -
Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy2022 Journal of the Endocrine Society article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Lennart J. van Winden, R. F. M. Vermeulen, Vincent van der Noort, Katja N. Gaarenstroom, Gemma G. Kenter, Monique M.A. Brood-van Zanten, +3 more
9citations -
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy2021 Gynecologic Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Miranda P. Steenbeek, Majke H.D. van Bommel, Marline G. Harmsen, Helena C. van Doorn, José H.M. Keurentjes, Marc van Beurden, +12 more
7citations -
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study2022 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Mark van Barele, Amy Rieborn, Bernadette A. M. Heemskerk‐Gerritsen, Inge-Marie Obdeijn, Linetta B. Koppert, Claudette E. Loo, +11 more
4citations -
Validation of the BOADICEA Multifactorial Breast Cancer Risk Prediction Model in a Large Prospective Study2022 SSRN Electronic Journal preprint Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Xin Yang, Mikael Eriksson, Kamila Czene, Andrew Lee, Goska Leslie, Michael Luch, +9 more
2citations -
Genetic correlation, and causal relationships between 3 solid cancer types and human traits2024 Network Modeling Analysis in Health Informatics and Bioinformatics article Biochemistry, Genetics and Molecular Biology Genetic Associations and Epidemiology
Claudia Cava, Ehsan Nazemalhosseini Mojarad, Isabella Castiglioni
1citations -
Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant2024 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Lara Terra, Naomi B. Boekel, Margriet J Collee, Marjanka K. Schmidt, Muriel A. Adank, Marleen Kok, +6 more
1citations -
Capturing breast cancers’ copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond2025 British Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Claire J.H. Kramer, Lise M. van Wijk, Dina Ruano, S. Gelpke-Vermeulen, Karin van der Tuin, Nienke van der Stoep, +10 more
1citations -
2022-RA-637-ESGO Five-year universal tumor screening of BRCA1/2 in epithelial ovarian carcinoma;is histotype-directed hr-deficiency testing justified?2022 International Journal of Gynecological Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Claire J.H. Kramer, Lieke Lanjouw, Arja ter Elst, Nienke Solleveld‐Westerink, Hans Marten Hazelbag, Marjolein J. Kagie, +14 more
0citations -
Rare Copy Number Variants (CNVs) and Breast Cancer Risk2021 Research Square preprint Biochemistry, Genetics and Molecular Biology Genomic variations and chromosomal abnormalities Open access
Joe Dennis, Jonathan P. Tyrer, Logan C. Walker, Kyriaki Michailidou, Leila Dorling, Manjeet Bola, +94 more
0citations -
72 Biomarker testing in patients with newly diagnosed advanced ovarian cancer – results from the first interim analysis of the non-interventional SCOUT-1 study (NOGGO Ov54, NCT04830709)2024 International Journal of Gynecological Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Elena Ioana Braicu, Pauline Wimberger, Klaus Pietzner, Jessika Goldmann, Karol Kubiak, Nikolaus de Gregorio, +14 more
0citations